Federal recipient
VGX Pharmaceuticals, LLC
$0 committed in FY2025 — no awards to them that year.See all years →Jump to FY2018 →
- Parent company
- Inovio Pharmaceuticals, Inc.
- District
- PA-07
- Location
- 660 W Germantown Pike Ste 110, Plymouth Meeting, PA, 19462
- UEI
- GK83K7A8Z9M9
- DUNS
- 063784784
- Also known as
- VGX Pharmaceuticals Inc
What they sell
Top products and services VGX Pharmaceuticals, LLC sells the government under contract, by dollars committed.
R&D- Medical: Aids Research (Basic Research)
$24.3M
Competition
How many of VGX Pharmaceuticals, LLC's priced contract actions drew exactly one offer — a competition on paper with a single bidder. A high share doesn't prove anything improper; it's a flag worth a second look.
Multiple offers
2
100%
What budget it comes from
The Treasury accounts VGX Pharmaceuticals, LLC's awards draw on. Dollars committed on awards that span more than one account are split evenly across them.
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Health and Human Services
075-0885
$24.3M
1 awards
Committed by fiscal year
Dollars committed to VGX Pharmaceuticals, LLC, per fiscal year (FY2018–FY2018).
How to read these numbers
- Committed to this recipient
The dollars agencies committed to them — signed contracts and awarded grants — counted in the year each action happened.
- Lifetime vs. a single year
The profile sections cover the recipient's full history on record; the headline total and the flow bar reflect the fiscal year picked at the top.
- “Active in FY X”
A fiscal-year award list shows every award with at least one action that year, at its full lifetime value — a different lens from the by-year chart, which splits each award across the years it was committed.
- Names come raw
Recipient names appear exactly as filed, and the government doesn't standardize them, so one organization can show up under a few spelling variants — worth checking near-duplicates before sizing one up.
- The colored bars
Every bar on this page splits by how the money moves:
Direct payments
